Risk Factors for Infusion Reactions Associated With Rituximab Therapy
Elevated pre-medication levels of CRP are a significant risk factor associated with the use of rituximab, thereby highlighting the need for close monitoring of patients receiving rituximab who present with elevated CRP levels prior to the initiation of therapy.
Authors
- Takahiro Amemiya
- Hiroshi Suzuki (ORCID: https://orcid.org/0000-0003-4682-5086)
Institutions
- Teikyo Heisei University (JP)
- University of Tokyo Hospital (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-09-01
- DOI
- https://doi.org/10.21873/cdp.10469
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00